TIA Pipeline Accelerator Voucher Program

The Centre for Drug Candidate Optimisation (CDCO) is proud to be part of Therapeutic Innovation Australia (TIA), offering specialised support for early-stage drug discovery programs.

Through the TIA Pipeline Accelerator voucher program, eligible Australian-based researchers and SMEs can access up to $50,000 in funding (matched by applicant's organisation) to fast-track their projects. This competitive scheme is designed to provide rapid access to expert services and facilities, helping promising therapies move closer to clinical application.

Key Details:

Who can apply? Australian-based universities, research organisations and SMEs.

Funding available: Up to $50,000 (plus matched co-investment) for a 1 year program

Round 2 (2025–2026) is now open. Applications close Friday 30 October 2020, 5.00PM AEST.

We are happy to assist with TIA applications, and we can provide technical guidance, advice and quotations to support your application. If you are interested in applying , please contact us by Friday 16th October.

Contact us